Sierra Bancorp director sells 5,000 shares

Sierra Bancorp director Lynda Scearcy reported option exercises and a share sale in the bank’s stock.

Rhea-AI Filing Summary

Sierra Bancorp director Lynda Scearcy reported option exercises and a share sale in the bank’s stock. On January 15, 2026, she exercised 5,000 stock options for Sierra Bancorp common stock at an exercise price of $28.21 per share, receiving 5,000 shares.

That same day, Scearcy reported selling 5,000 shares of common stock at a price of $35 per share. The filing notes that the sale was a “Sale of shares of common stock under the 10b5-1 Plan.” After the reported transactions, she continued to hold a substantial number of Sierra Bancorp shares directly.

Insider Trade Summary

Exercise and Sale: 5,000 shares ($34K approx. pre-tax spread)

Exercise and Sale 4 txns

Insider Scearcy Lynda

Role Director

Sold 5,000 shs ($175K)

Approx. gross sale proceeds $175K

Approx. exercise cost $141K

Approx. pre-tax spread $34K

Type	Security	Shares	Price	Value
Exercise	Stock Options	5,000	$0.00	$0.00
Exercise	Common Stock	5,000	$28.21	$141K
Sale	Common Stock	5,000	$35.00	$175K
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Options — 0 contracts (Direct); Common Stock — 41,271.72 shares (Direct)

Footnotes (1)

1. F1. Sale of shares of common stock under the 10b5-1 Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Lynda Scearcy report for Sierra Bancorp (BSRR)?

Lynda Scearcy, a director of Sierra Bancorp, reported exercising 5,000 stock options for common stock and selling 5,000 shares of Sierra Bancorp common stock on January 15, 2026.

At what prices did Lynda Scearcy exercise and sell Sierra Bancorp (BSRR) shares?

Scearcy exercised 5,000 stock options at an exercise price of $28.21 per share and sold 5,000 common shares at $35 per share.

Was the Sierra Bancorp (BSRR) share sale by Lynda Scearcy under a 10b5-1 plan?

Yes. A footnote states the transaction was a “Sale of shares of common stock under the 10b5-1 Plan.”

What type of securities did Lynda Scearcy exercise in the Sierra Bancorp Form 4?

She exercised stock options that were exercisable for 5,000 shares of Sierra Bancorp common stock at an exercise price of $28.21.

What is Lynda Scearcy’s relationship to Sierra Bancorp (BSRR)?

Lynda Scearcy is listed in the filing as a director of Sierra Bancorp. She is not identified as an officer or 10% owner.

How many Sierra Bancorp (BSRR) shares did Lynda Scearcy hold after the reported sale?

After selling 5,000 shares at $35, the Form 4 shows 30,132.72 shares of Sierra Bancorp common stock beneficially owned directly following that transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/16/2026 - 02:35 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Scearcy Lynda

(Last) (First) (Middle)

86 N. MAIN STREET

(Street)

PORTERVILLE CA 93257

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SIERRA BANCORP [ BSRR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/15/2026		M		5,000	A	$28.21	35,132.72	D
Common Stock	01/15/2026		S		5,000(1)	D	$35	30,132.72	D
Common Stock								11,139	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	$28.21	01/15/2026		M			5,000	02/16/2017	02/16/2027	Common Stock	5,000	$0	0	D

Explanation of Responses:

1. Sale of shares of common stock under the 10b5-1 Plan.

	/s/ Lynda Scearcy	01/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.